Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Kent Hutchison to Middle Aged

This is a "connection" page, showing publications Kent Hutchison has written about Middle Aged.

 
Connection Strength
  
 
 
1.186
  
  1. Skrzynski CJ, Bryan AD, Hutchison KE. Mindfulness mechanisms in alcohol use: Comparing top-down and bottom-up processes. Psychol Addict Behav. 2024 Feb; 38(1):92-100.
    View in: PubMed
    Score: 0.047
  2. Skrzynski CJ, Karoly H, Ellingson JM, Hagerty SL, Bryan AD, Hutchison KE. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial. J Stud Alcohol Drugs. 2023 07; 84(4):560-569.
    View in: PubMed
    Score: 0.046
  3. Karoly HC, Skrzynski CJ, Moe EN, Bryan AD, Hutchison KE. Exploring relationships between alcohol consumption, inflammation, and brain structure in a heavy drinking sample. Alcohol Clin Exp Res. 2021 11; 45(11):2256-2270.
    View in: PubMed
    Score: 0.042
  4. Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, Bryan AD, Bidwell LC, Hutchison KE. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022 01; 27(1):e13092.
    View in: PubMed
    Score: 0.042
  5. Bidwell LC, Karoly HC, Thayer RE, Claus ED, Bryan AD, Weiland BJ, YorkWilliams S, Hutchison KE. DRD2 promoter methylation and measures of alcohol reward: functional activation of reward circuits and clinical severity. Addict Biol. 2019 05; 24(3):539-548.
    View in: PubMed
    Score: 0.033
  6. Mayer AR, Hanlon FM, Claus ED, Dodd AB, Miller B, Mickey J, Quinn DK, Hagerty SL, Seaman B, Hutchison KE. An Examination of Behavioral and Neuronal Effects of Comorbid Traumatic Brain Injury and Alcohol Use. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 03; 3(3):294-302.
    View in: PubMed
    Score: 0.032
  7. Littlewood RA, Claus ED, Wilcox CE, Mickey J, Arenella PB, Bryan AD, Hutchison KE. Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo. Psychopharmacology (Berl). 2017 Dec; 234(23-24):3417-3429.
    View in: PubMed
    Score: 0.032
  8. Karoly HC, Thayer RE, Hagerty SL, Hutchison KE. TLR4 Methylation Moderates the Relationship Between Alcohol Use Severity and Gray Matter Loss. J Stud Alcohol Drugs. 2017 09; 78(5):696-705.
    View in: PubMed
    Score: 0.032
  9. Thayer RE, YorkWilliams S, Karoly HC, Sabbineni A, Ewing SF, Bryan AD, Hutchison KE. Structural neuroimaging correlates of alcohol and cannabis use in adolescents and adults. Addiction. 2017 Dec; 112(12):2144-2154.
    View in: PubMed
    Score: 0.032
  10. Gardiner CK, YorkWilliams SL, Bryan AD, Hutchison KE. Body mass is positively associated with neural response to sweet taste, but not alcohol, among drinkers. Behav Brain Res. 2017 07 28; 331:131-134.
    View in: PubMed
    Score: 0.031
  11. Wilcox CE, Calhoun VD, Rachakonda S, Claus ED, Littlewood RA, Mickey J, Arenella PB, Hutchison KE. Functional network connectivity predicts treatment outcome during treatment of nicotine use disorder. Psychiatry Res Neuroimaging. 2017 Jul 30; 265:45-53.
    View in: PubMed
    Score: 0.031
  12. Wilcox CE, Claus ED, Calhoun VD, Rachakonda S, Littlewood RA, Mickey J, Arenella PB, Goodreau N, Hutchison KE. Default mode network deactivation to smoking cue relative to food cue predicts treatment outcome in nicotine use disorder. Addict Biol. 2018 01; 23(1):412-424.
    View in: PubMed
    Score: 0.031
  13. Hagerty SL, Bidwell LC, Harlaar N, Hutchison KE. An Exploratory Association Study of Alcohol Use Disorder and DNA Methylation. Alcohol Clin Exp Res. 2016 08; 40(8):1633-40.
    View in: PubMed
    Score: 0.029
  14. Monnig MA, Yeo RA, Tonigan JS, McCrady BS, Thoma RJ, Sabbineni A, Hutchison KE. Associations of White Matter Microstructure with Clinical and Demographic Characteristics in Heavy Drinkers. PLoS One. 2015; 10(11):e0142042.
    View in: PubMed
    Score: 0.028
  15. Littlewood RA, Claus ED, Arenella P, Bogenschutz M, Karoly H, Ewing SW, Bryan AD, Hutchison KE. Dose specific effects of olanzapine in the treatment of alcohol dependence. Psychopharmacology (Berl). 2015 Apr; 232(7):1261-8.
    View in: PubMed
    Score: 0.026
  16. Weiland BJ, Sabbineni A, Calhoun VD, Welsh RC, Bryan AD, Jung RE, Mayer AR, Hutchison KE. Reduced left executive control network functional connectivity is associated with alcohol use disorders. Alcohol Clin Exp Res. 2014 Sep; 38(9):2445-53.
    View in: PubMed
    Score: 0.026
  17. Karoly HC, Weiland BJ, Sabbineni A, Hutchison KE. Preliminary functional MRI results from a combined stop-signal alcohol-cue task. J Stud Alcohol Drugs. 2014 Jul; 75(4):664-73.
    View in: PubMed
    Score: 0.026
  18. Monnig MA, Thayer RE, Caprihan A, Claus ED, Yeo RA, Calhoun VD, Hutchison KE. White matter integrity is associated with alcohol cue reactivity in heavy drinkers. Brain Behav. 2014 Mar; 4(2):158-70.
    View in: PubMed
    Score: 0.025
  19. Bryan AD, Magnan RE, Hooper AE, Ciccolo JT, Marcus B, Hutchison KE. Colorado stride (COSTRIDE): testing genetic and physiological moderators of response to an intervention to increase physical activity. Int J Behav Nutr Phys Act. 2013 Dec 21; 10:139.
    View in: PubMed
    Score: 0.025
  20. Harlaar N, Bryan AD, Thayer RE, Karoly HC, Oien N, Hutchison KE. Methylation of a CpG site near the ALDH1A2 gene is associated with loss of control over drinking and related phenotypes. Alcohol Clin Exp Res. 2014 Mar; 38(3):713-21.
    View in: PubMed
    Score: 0.025
  21. Claus ED, Blaine SK, Filbey FM, Mayer AR, Hutchison KE. Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology. 2013 Nov; 38(12):2363-72.
    View in: PubMed
    Score: 0.024
  22. Karoly HC, Stevens CJ, Thayer RE, Magnan RE, Bryan AD, Hutchison KE. Aerobic exercise moderates the effect of heavy alcohol consumption on white matter damage. Alcohol Clin Exp Res. 2013 Sep; 37(9):1508-15.
    View in: PubMed
    Score: 0.024
  23. Claus ED, Feldstein Ewing SW, Filbey FM, Hutchison KE. Behavioral control in alcohol use disorders: relationships with severity. J Stud Alcohol Drugs. 2013 Jan; 74(1):141-51.
    View in: PubMed
    Score: 0.023
  24. Yeo RA, Thoma RJ, Gasparovic C, Monnig M, Harlaar N, Calhoun VD, Kalyanam R, Mayer AR, Durazzo TC, Hutchison KE. Neurometabolite concentration and clinical features of chronic alcohol use: a proton magnetic resonance spectroscopy study. Psychiatry Res. 2013 Feb 28; 211(2):141-7.
    View in: PubMed
    Score: 0.023
  25. Claus ED, Hutchison KE. Neural mechanisms of risk taking and relationships with hazardous drinking. Alcohol Clin Exp Res. 2012 Jun; 36(6):932-40.
    View in: PubMed
    Score: 0.022
  26. Liu J, Calhoun VD, Chen J, Claus ED, Hutchison KE. Effect of homozygous deletions at 22q13.1 on alcohol dependence severity and cue-elicited BOLD response in the precuneus. Addict Biol. 2013 May; 18(3):548-58.
    View in: PubMed
    Score: 0.021
  27. Yeo RA, Gangestad SW, Gasparovic C, Liu J, Calhoun VD, Thoma RJ, Mayer AR, Kalyanam R, Hutchison KE. Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders. Biol Psychiatry. 2011 Sep 15; 70(6):537-44.
    View in: PubMed
    Score: 0.021
  28. Claus ED, Ewing SW, Filbey FM, Sabbineni A, Hutchison KE. Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology. 2011 Sep; 36(10):2086-96.
    View in: PubMed
    Score: 0.021
  29. Claus ED, Kiehl KA, Hutchison KE. Neural and behavioral mechanisms of impulsive choice in alcohol use disorder. Alcohol Clin Exp Res. 2011 Jul; 35(7):1209-19.
    View in: PubMed
    Score: 0.021
  30. Yeo RA, Gangestad SW, Liu J, Calhoun VD, Hutchison KE. Rare copy number deletions predict individual variation in intelligence. PLoS One. 2011 Jan 26; 6(1):e16339.
    View in: PubMed
    Score: 0.020
  31. Feldstein Ewing SW, Filbey FM, Sabbineni A, Chandler LD, Hutchison KE. How psychosocial alcohol interventions work: a preliminary look at what FMRI can tell us. Alcohol Clin Exp Res. 2011 Apr; 35(4):643-51.
    View in: PubMed
    Score: 0.020
  32. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology. 2010 Mar; 35(4):967-75.
    View in: PubMed
    Score: 0.019
  33. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Marijuana craving in the brain. Proc Natl Acad Sci U S A. 2009 Aug 04; 106(31):13016-21.
    View in: PubMed
    Score: 0.018
  34. Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 2007 Sep; 64(9):1078-86.
    View in: PubMed
    Score: 0.016
  35. Ray LA, Rhee SH, Stallings MC, Knopik V, Hutchison KE. Examining the heritability of a laboratory-based smoking endophenotype: initial results from an experimental twin study. Twin Res Hum Genet. 2007 Aug; 10(4):546-53.
    View in: PubMed
    Score: 0.016
  36. Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology. 2006 Jun; 31(6):1310-7.
    View in: PubMed
    Score: 0.015
  37. Qiu L, Liang C, Kochunov P, Hutchison KE, Sui J, Jiang R, Zhi D, Vergara VM, Yang X, Zhang D, Fu Z, Bustillo JR, Qi S, Calhoun VD. Associations of alcohol and tobacco use with psychotic, depressive and developmental disorders revealed via multimodal neuroimaging. Transl Psychiatry. 2024 Aug 07; 14(1):326.
    View in: PubMed
    Score: 0.013
  38. Lin D, Fu Z, Liu J, Perrone-Bizzozero N, Hutchison KE, Bustillo J, Du Y, Pearlson G, Calhoun VD. Association between the oral microbiome and brain resting state connectivity in schizophrenia. Schizophr Res. 2024 08; 270:392-402.
    View in: PubMed
    Score: 0.013
  39. Bidwell LC, Martin-Willett R, Skrzynski C, Lisano J, Ortiz Torres M, Giordano G, Hutchison KE, Bryan AD. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study. Cannabis Cannabinoid Res. 2024 Aug; 9(4):1015-1027.
    View in: PubMed
    Score: 0.012
  40. Cao Z, Ottino-Gonzalez J, Cupertino RB, Schwab N, Hoke C, Catherine O, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Li CR, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Momenan R, Paulus MP, Schmaal L, Sinha R, Sjoerds Z, Solowij N, Stein DJ, Stein EA, Uhlmann A, van Holst RJ, Veltman DJ, Wiers RW, Y?cel M, Zhang S, Jahanshad N, Thompson PM, Conrod P, Mackey S, Garavan H. Mapping cortical and subcortical asymmetries in substance dependence: Findings from the ENIGMA Addiction Working Group. Addict Biol. 2021 09; 26(5):e13010.
    View in: PubMed
    Score: 0.010
  41. YorkWilliams SL, Gibson LP, Gust CJ, Giordano G, Hutchison KE, Bryan AD. Exercise Intervention Outcomes with Cannabis Users and Nonusers Aged 60 and Older. Am J Health Behav. 2020 07 01; 44(4):420-431.
    View in: PubMed
    Score: 0.010
  42. Hagerty SL, Hutchison KE, Lowry CA, Bryan AD. An empirically derived method for measuring human gut microbiome alpha diversity: Demonstrated utility in predicting health-related outcomes among a human clinical sample. PLoS One. 2020; 15(3):e0229204.
    View in: PubMed
    Score: 0.009
  43. Hutchison KE, Niaura R, Swift R. Smoking cues decrease prepulse inhibition of the startle response and increase subjective craving in humans. Exp Clin Psychopharmacol. 1999 Aug; 7(3):250-6.
    View in: PubMed
    Score: 0.009
  44. Lin D, Hutchison KE, Portillo S, Vegara V, Ellingson JM, Liu J, Krauter KS, Carroll-Portillo A, Calhoun VD. Association between the oral microbiome and brain resting state connectivity in smokers. Neuroimage. 2019 10 15; 200:121-131.
    View in: PubMed
    Score: 0.009
  45. Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug Alcohol Depend. 2019 07 01; 200:181-190.
    View in: PubMed
    Score: 0.009
  46. Thayer RE, YorkWilliams SL, Hutchison KE, Bryan AD. Preliminary results from a pilot study examining brain structure in older adult cannabis users and nonusers. Psychiatry Res Neuroimaging. 2019 03 30; 285:58-63.
    View in: PubMed
    Score: 0.009
  47. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, Brooks S, Caparelli E, Chye YY, Cousijn J, Dagher A, Desrivieres S, Feldstein-Ewing S, Foxe JJ, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hester R, Hutchison K, Korucuoglu O, Li CR, London E, Lorenzetti V, Luijten M, Martin-Santos R, May A, Momenan R, Morales A, Paulus MP, Pearlson G, Rousseau ME, Salmeron BJ, Schluter R, Schmaal L, Schumann G, Sjoerds Z, Stein DJ, Stein EA, Sinha R, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Whittle S, Wright MJ, Y?cel M, Zhang S, Yurgelun-Todd D, Hibar DP, Jahanshad N, Evans A, Thompson PM, Glahn DC, Conrod P, Garavan H. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. Am J Psychiatry. 2019 02 01; 176(2):119-128.
    View in: PubMed
    Score: 0.009
  48. Vergara VM, Weiland BJ, Hutchison KE, Calhoun VD. The Impact of Combinations of Alcohol, Nicotine, and Cannabis on Dynamic Brain Connectivity. Neuropsychopharmacology. 2018 03; 43(4):877-890.
    View in: PubMed
    Score: 0.008
  49. Vergara VM, Liu J, Claus ED, Hutchison K, Calhoun V. Alterations of resting state functional network connectivity in the brain of nicotine and alcohol users. Neuroimage. 2017 05 01; 151:45-54.
    View in: PubMed
    Score: 0.008
  50. Hutchison KE, Stevens VM, Collins FL. Cigarette smoking and the intention to quit among pregnant smokers. J Behav Med. 1996 Jun; 19(3):307-16.
    View in: PubMed
    Score: 0.007
  51. Vergara VM, Mayer AR, Damaraju E, Hutchison K, Calhoun VD. The effect of preprocessing pipelines in subject classification and detection of abnormal resting state functional network connectivity using group ICA. Neuroimage. 2017 01 15; 145(Pt B):365-376.
    View in: PubMed
    Score: 0.007
  52. Thayer RE, Hagerty SL, Sabbineni A, Claus ED, Hutchison KE, Weiland BJ. Negative and interactive effects of sex, aging, and alcohol abuse on gray matter morphometry. Hum Brain Mapp. 2016 06; 37(6):2276-92.
    View in: PubMed
    Score: 0.007
  53. Chen J, Hutchison KE, Calhoun VD, Claus ED, Turner JA, Sui J, Liu J. CREB-BDNF pathway influences alcohol cue-elicited activation in drinkers. Hum Brain Mapp. 2015 Aug; 36(8):3007-19.
    View in: PubMed
    Score: 0.007
  54. Kalyanam R, Boutte D, Hutchison KE, Calhoun VD. Application of ICA to realistically simulated (1)H-MRS data. Brain Behav. 2015 Jul; 5(7):e00345.
    View in: PubMed
    Score: 0.007
  55. Hoefer ME, Pennington DL, Durazzo TC, Mon A, Ab? C, Truran D, Hutchison KE, Meyerhoff DJ. Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. Alcohol. 2014 Nov; 48(7):631-8.
    View in: PubMed
    Score: 0.006
  56. Ray LA, Sehl M, Bujarski S, Hutchison K, Blaine S, Enoch MA. The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G ? E effects. Genes Brain Behav. 2013 Jun; 12(4):361-9.
    View in: PubMed
    Score: 0.006
  57. Mon A, Durazzo TC, Gazdzinski S, Hutchison KE, Pennington D, Meyerhoff DJ. Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals. Genes Brain Behav. 2013 Feb; 12(1):98-107.
    View in: PubMed
    Score: 0.006
  58. Boutte D, Calhoun VD, Chen J, Sabbineni A, Hutchison K, Liu J. Association of genetic copy number variations at 11 q14.2 with brain regional volume differences in an alcohol use disorder population. Alcohol. 2012 Sep; 46(6):519-27.
    View in: PubMed
    Score: 0.006
  59. Hoft NR, Stitzel JA, Hutchison KE, Ehringer MA. CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences. Genes Brain Behav. 2011 Mar; 10(2):176-85.
    View in: PubMed
    Score: 0.005
  60. Ray LA, Hutchison KE, Leventhal AM, Miranda R, Francione C, Chelminski I, Young D, Zimmerman M. Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications. Addict Behav. 2009 Jun-Jul; 34(6-7):587-92.
    View in: PubMed
    Score: 0.004
  61. Duncan LE, Hutchison KE, Carey G, Craighead WE. Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J Affect Disord. 2009 May; 115(1-2):215-9.
    View in: PubMed
    Score: 0.004
  62. Rohsenow DJ, Tidey JW, Miranda R, McGeary JE, Swift RM, Hutchison KE, Sirota AD, Monti PM. Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp Clin Psychopharmacol. 2008 Jun; 16(3):215-22.
    View in: PubMed
    Score: 0.004
  63. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol. 2007 Feb; 15(1):81-92.
    View in: PubMed
    Score: 0.004
  64. David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
    View in: PubMed
    Score: 0.003
  65. Davidson D, Hutchison K, Dagon C, Swift R. Assessing the stimulant effects of alcohol in humans. Pharmacol Biochem Behav. 2002 May; 72(1-2):151-6.
    View in: PubMed
    Score: 0.003
  66. Shadel WG, Niaura R, Brown RA, Hutchison KE, Abrams DB. A content analysis of smoking craving. J Clin Psychol. 2001 Jan; 57(1):145-50.
    View in: PubMed
    Score: 0.003
  67. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol. 2000 Nov; 109(4):738-42.
    View in: PubMed
    Score: 0.002
  68. Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB. Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res. 1999 Aug; 23(8):1386-94.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)